A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin

This publication has 25 references indexed in Scilit:

• Insulin resistance and lipoprotein metabolism
  Current Opinion in Lipidology, 1995
• Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy
  Atherosclerosis, 1994
• Postprandial changes in apolipoprotein(a) concentration of triglyceride-rich lipoproteins can be reproduced by in vitro incubation: implications for underlying mechanism
  Atherosclerosis, 1993
• Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia
  Atherosclerosis, 1993
• Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion
  Metabolism, 1993
• Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome
  Atherosclerosis, 1993
• Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non‐familial hypercholesterolaemia
  Journal of Internal Medicine, 1991
• Influence of lovastatin on concentrations and composition of lipoprotein subfractions
  Atherosclerosis, 1990
• Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
  Journal of Clinical Investigation, 1973